USP Drug Quality Pilot Program Underway in Sub-Saharan Africa - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

USP Drug Quality Pilot Program Underway in Sub-Saharan Africa


ePT--the Electronic Newsletter of Pharmaceutical Technology

Untitled Document

On Apr. 18, 2011, scientists from the national laboratories of five African nations gathered in Accra, Ghana, to take part in a week of technical training put on by the US Pharmacopeia (USP) that will teach them how to detect substandard and counterfeit medicines.

USP is providing participants from Ethiopia, Ghana, Kenya, Senegal, and Sierra Leone with pharmaceutical reference standards, documentary standards, and technical writing training in an effort to improve help the quality of those countries’ medicines.  The instruction is a part of a pilot Technical Assistance Program (TAP) that was introduced earlier this year and funded by USP.

USP developed TAP based on feedback from participants about topics they wanted to see addressed most.  National laboratories in these countries often have to rely on unreliable or outdated standards to analyze medicines. The laboratories also may not be equipped to offer analysts the scientific training needed to appropriately analyze medicines.

As a result, accurate outcomes may not be obtained when questionable substances are tested. “Having a team of scientists trained in essential analytical techniques is a fundamental aspect of a well-functioning regulatory system that protects domestic drug supply,” said Patrick Lukulay, director of the PQM program in a USP press release.

The objective of the training is to improve the technical competence of the scientists and familiarize participants with information contained in the USP-NF, including how to use the information, according to the USP release.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here